(Q38069531)

28 August 2017

1 reference

title

EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients (English)

1 reference

Adrianus Henricus Maria Geurts van Kessel

28 August 2017

1 reference

3

object named as

Ad Geurts van Kessel

0 references

Nicoline Hoogerbrugge

4

object named as

Nicoline Hoogerbrugge

1 reference

28 August 2017

Marjolijn J L Ligtenberg

1

object named as

Marjolijn J L Ligtenberg

1 reference

28 August 2017

Roland P Kuiper

2

1 reference

28 August 2017

Ad Geurts van Kessel

3

1 reference

28 August 2017

publication date

1 June 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

12

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

169-174

1 reference

Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Epimutations and cancer predisposition: importance and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

EPCAM germ line deletions as causes of Lynch syndrome in Spanish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Recurrence and variability of germline EPCAM deletions in Lynch syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

The emerging role of EpCAM in cancer and stem cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Epithelial cell adhesion molecule expression (CD326) in cancer: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Lessons from common markers of tumor-initiating cells in solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Identification of EpCAM as the gene for congenital tufting enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

Molecular characterization of the spectrum of genomic deletions in the mismatch repair genesMSH2,MLH1,MSH6, andPMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10689-012-9591-X

The 5' region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences

21 January 2018

1 reference

12 December 2020

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study

1 reference

12 December 2020

Colon-specific phenotype in Lynch syndrome associated with EPCAM deletion

1 reference

12 December 2020

Analysis of EPCAM protein expression in diagnostics of Lynch syndrome

1 reference

12 December 2020

Further evidence for EpCAM as the gene for congenital tufting enteropathy

1 reference

12 December 2020

10.1007/S10689-012-9591-X

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1044283239

0 references

1 reference